The acquisition is the latest in a spate of big pharma deals this year as many companies are strengthening their portfolios as old drugs go generic

AbbVie is to buy Pharmacyclics for about $21 billion, giving it access to what is expected to be one of the world’s top-selling cancer drugs and expan(...)

Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)

Gerard Whelan, managing director of Brandcentral

What is unique about your business? My international experience. I’ve done a lot of work in Scandinavia and a global project for Johnson & Johnson(...)

Dozens of cases being taken against the manufacturers of allegedly defective hip replacements may be struck out following a ruling by the High Court.

Dozens of cases being taken against the manufacturers of allegedly defective hip replacements may be struck out following a ruling by the High Court. (...)

Aer Lingus finished down 1.9 per cent at €2.37 during a reasonably active session for the stock

Optimism among investors that the European Central Bank will begin quantitative easing later this week pushed stock prices up to a new seven-year hig(...)

On a high: the continued advance of equities means one influential strategist sees almost no value in the US market and precious little elsewhere.Photograph: Brendan McDermid/Reuters

The US stock market is “hideously expensive,” according to James Montier, an influential strategist with GMO, a global investment management firm bas(...)

Approximately 100 new jobs have been announced in Limerick by a division of medtech giant Johnson & Johnson. Information Technology Shared Service(...)

An Ebola patient arriving at Geneva University Hospital HUG in Geneva, Switzerland on November 21st. Early safety trials for a new vaccine to combat the deadly disease have had encouraging results. Photograph: EPA/Julien Gregorio

An experimental Ebola vaccine caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-(...)

J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of Tuesday had a market capitalisation of $17.8 billion

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback (...)

Virgin America president David Cush in the New York Stock Exchange yesterday before the company’s shares’ first day of trading. Photograph: Michael Loccisano/Getty Images

European stocks were little changed as slides in healthcare and commodity stocks offset gains in media companies.Eurostat, the EU’s official number c(...)